5 completed, 1 active not recruiting, 1 not yet recruiting, 1 withdrawn. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 5, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1 |
Follow drospirenone: new trials by email Literature Review of drospirenone trials Research Report on drospirenone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia Norethindrone 0.35 MG, Drospirenone - Hypertension, Preeclampsia | Phase 4 | Not yet recruiting | Oregon Health and Science University | 50 | 2026-07-01 | 2025-12-19 |
| The Use of Drospirenone/Estetrol in Random Start Rapid Endometrial Preparation drospirenone/estetrol 3mg/14.2mg - Endometrial Polyp, Endometrial Diseases | Phase 4 | Completed | University of Palermo | 80 | 2023-01-01 | 2024-04-08 |
| LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women drospirenone 4 mg oral tablet or drospirenone 3.5 mg chewable tablet - Change in Bone Mineral Density, Bone Loss | Phase 4 | Active not recruiting | Insud Pharma | 1536 | 2022-03-28 | 2026-04-09 |
| Treatment Choice in Primary Dysmenorrhea estradiol valerate/dienogest, ethinylestradiol and drospirenone - Primary Dysmenorrhea | Phase 4 | Completed | Adana Numune Training and Research Hospital | 99 | 2015-01-15 | 2017-04-26 |
| The Effect of Oral Contraceptives on Women Balance COC containing 30 μg of EE and 3mg of drospirenone - Joint Stabilioty | Phase 4 | Completed | Cairo University | 100 | 2015-01-01 | 2016-08-04 |
| Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality YASMIN® (Drospirenone/Ethinyl Estradiol), The Copper-T is an intrauterine device (IUD), levonorgestrel-releasing system - Contraceptive Methods Comparison | Phase 4 | Withdrawn | Istanbul Training and Research Hospital | 2012-12-01 | 2020-08-13 | |
| Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone EE 20 microgram with desogestrel 150 mg, EE 20 microgram with drospirenone 3 mg - Premenstrual Syndrome | Phase 4 | Completed | Chulalongkorn University | 90 | 2011-06-01 | 2012-03-14 |
| Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women Yasmin (DRSP 3mg/EE 0.03 mg), Microgynon (LNG 0.15 mg/EE 0.03 mg) - Healthy | Phase 4 | Completed | Bayer | 43 | 2003-06-01 | 2014-12-30 |
Bone Diseases, Metabolic (1) · Hypertension (1) · Osteoporosis (1) · Pelvic Pain (1) · Pre-Eclampsia (1) · Premenstrual Syndrome (1) · Thrombosis (1) · Uterine Diseases (1)
Adana Numune Training and Research Hospital (1) · Bayer (1) · Cairo University (1) · Chulalongkorn University (1) · Insud Pharma (1) · Istanbul Training and Research Hospital (1) · Oregon Health and Science University (1) · University of Palermo (1)
United States (2) · Czechia (1) · Egypt (1) · Germany (1) · Italy (1) · Poland (1) · Thailand (1) · Turkey (Türkiye) (1)
Ahmed Maged, MD (1) · Enrico Colli, MD (1) · Gulsum Uysal, M.D (1) · Jirath Wichianpitaya, M.D. (1) · Julia Tasset (1) · Surasak Taneepanichskul, M.D. (1)